Overview

Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Herniorrhaphy

Status:
COMPLETED
Trial end date:
2025-03-12
Target enrollment:
Participant gender:
Summary
MR-107A-02 is being studied to investigate its efficacy and safety for treatment of acute pain after herniorrhaphy.
Phase:
PHASE3
Details
Lead Sponsor:
Viatris Specialty LLC
Collaborator:
Mylan Specialty, LP
Treatments:
Tramadol